Silent thyroiditis epidemiology and demographics: Difference between revisions

	Silent thyroiditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Silent thyroiditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Silent thyroiditis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Silent thyroiditis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Silent thyroiditis epidemiology and demographics
CDC on Silent thyroiditis epidemiology and demographics
Silent thyroiditis epidemiology and demographics in the news
Blogs on Silent thyroiditis epidemiology and demographics
Directions to Hospitals Treating Silent thyroiditis
Risk calculators and risk factors for Silent thyroiditis epidemiology and demographics

Revision as of 17:42, 18 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S [2]

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
The case-fatality rate of [disease name] is approximately [number range].

Patients of all age groups may develop [disease name].
The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
[Chronic disease name] is usually first diagnosed among [age group].
[Acute disease name] commonly affects [age group].

[Disease name] affects men and women equally.
Females are more commonly affected by silent thyroiditis than males. The female to male ratio is approximately 4 to 1.^[1]

[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

↑ Pearce EN, Farwell AP, Braverman LE (2003). "Thyroiditis". N. Engl. J. Med. 348 (26): 2646–55. doi:10.1056/NEJMra021194. PMID 12826640.

@@ Line 30: / Line 30: @@
 ===Gender===
 *[Disease name] affects men and women equally.
-*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
+*Females are more commonly affected by silent thyroiditis than males. The female to male ratio is approximately 4 to 1.<ref name="pmid12826640">{{cite journal |vauthors=Pearce EN, Farwell AP, Braverman LE |title=Thyroiditis |journal=N. Engl. J. Med. |volume=348 |issue=26 |pages=2646–55 |year=2003 |pmid=12826640 |doi=10.1056/NEJMra021194 |url=}}</ref>
 ===Region===
 *The majority of [disease name] cases are reported in [geographical region].